- Home
- ANIP vs RCKT Comparison
ANIP vs RCKT Comparison
Compare ANIP & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- RCKT
- Stock Information
- Founded
- ANIP 2001
- RCKT 1999
- Country
- ANIP United States
- RCKT United States
- Employees
- ANIP N/A
- RCKT N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ANIP Health Care
- RCKT Health Care
- Exchange
- ANIP Nasdaq
- RCKT Nasdaq
- Market Cap
- ANIP 1.2B
- RCKT 1.1B
- IPO Year
- ANIP N/A
- RCKT N/A
- Fundamental
- Price
- ANIP $61.52
- RCKT $8.47
- Analyst Decision
- ANIP Buy
- RCKT Strong Buy
- Analyst Count
- ANIP 8
- RCKT 10
- Target Price
- ANIP $79.71
- RCKT $44.10
- AVG Volume (30 Days)
- ANIP 275.5K
- RCKT 1.3M
- Earning Date
- ANIP 05-09-2025
- RCKT 05-05-2025
- Dividend Yield
- ANIP N/A
- RCKT N/A
- EPS Growth
- ANIP N/A
- RCKT N/A
- EPS
- ANIP N/A
- RCKT N/A
- Revenue
- ANIP $614,376,000.00
- RCKT N/A
- Revenue This Year
- ANIP $26.80
- RCKT N/A
- Revenue Next Year
- ANIP $6.89
- RCKT $307.50
- P/E Ratio
- ANIP N/A
- RCKT N/A
- Revenue Growth
- ANIP 26.20
- RCKT N/A
- 52 Week Low
- ANIP $52.50
- RCKT $8.06
- 52 Week High
- ANIP $70.81
- RCKT $28.73
- Technical
- Relative Strength Index (RSI)
- ANIP 60.64
- RCKT 39.40
- Support Level
- ANIP $57.72
- RCKT $8.06
- Resistance Level
- ANIP $64.43
- RCKT $9.35
- Average True Range (ATR)
- ANIP 2.77
- RCKT 0.58
- MACD
- ANIP 0.50
- RCKT -0.06
- Stochastic Oscillator
- ANIP 86.50
- RCKT 24.52
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.